Induction of human leukaemic mast cell differentiation by fibroblast supernatants, but only by stem cell factor

Scandinavian Journal of Immunology

Volumn 47, Issue 4, 1998, Pages 324-331

  Grabbe, J ^a   Welker, P ^b   Grutzkau A ^b   Dippel, E ^b   Nurnberg W ^b   Zuberbier, T ^b   Henz, B M ^b,c  

^a UNIVERSITY OF LÜBECK   (Germany)

^b HUMBOLDT UNIVERSITY   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STEM CELL FACTOR;

ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; FIBROBLAST; HISTAMINE RELEASE; HUMAN; HUMAN CELL; MAST CELL; MAST CELL DEGRANULATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELL LINE; CHEMICAL FRACTIONATION; CULTURE MEDIA; FIBROBLASTS; HUMANS; LEUKEMIA; MAST CELLS; MICE; RECOMBINANT PROTEINS; RNA, MESSENGER; STEM CELL FACTOR; TUMOR CELLS, CULTURED;

EID: 0031976632     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1998.00307.x     Document Type: Article

References (51)

1. Galli SJ. New concepts about mast cells. N Engl J Med 1993; 328:257-65.
2. Weber S, Krüger-Krasagakes S, Grabbe J, Zuberbier T, Czarnetzki BM. Mast cells. Int J Dermatol 1995;34:1-10.
3. Czarnetzki BM, Grabbe J, Kolde G, Krüger-Krasagakes S, Zuberbier T. Mast cells in the cytokine network: the what, where from and what for. Exp Dermatol 1995;4:221-6.
4. Tsui K, Zsebo KM, Ogawa M. Murine mast cell colony formation supported by IL-3, IL-4 and recombinant rat stem cell factor, ligand for c-kit. J Cell Physiol 1991;148:362-9.
5. Tsai M, Takeishi T, Thomson H et al. Induction of mast cell proliferation, maturation, and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 1991;88:6382-6.
6. Kirshenbaum AS, Goff JP, Kessler SW, Mican JM, Zsebo KM, Metcalfe DD. Effect of IL-3 and stem cell factor on the appearance of human basophils and mast cells from CD34 pluripotent + progenitor cells. J Immunol 1992;148:772-7.
7. Valent PE, Spanböchl WR, Sparr C et al. Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by rhSCF/c-kit-ligand (KL) in long time culture. Blood 1992;80:2237-45.
8. Mitsui H, Furitsu T, Dvorak AM et al. Development of human mast cells from umbilical cord blood cells by recombinant human and murine c-kit ligand. Proc Natl Acad Sci USA 1993;90:735-9.
9. Valent P, Schmidt J, Besmer J et al. Interleukin 3 is a differentiation factor for human basophils. Blood 1989;73:1763-9.
10. Galli SJ, Zsebo JM, Geissler EN. The kit ligand, stem cell factor. Adv Immunol 1994;55:1-96.
11. Grabbe J, Welker P, Dippel E, Czarnetzki BM. Stem cell factor, a novel cutaneous growth factor for mast cells and melanocytes. Arch Dermatol Res 1994;287:78-84.
12. Grabbe J, Welker P, Rosenbach T et al. Release of stem cell factor from a human keratinocyte line, HaCaT, is increased in differentiating versus proliferating cells. J Invest Dermatol 1996; 107:219-24.
13. Ginsburg H, Ben-Shahar D, Ben-David E. Mast cell growth on fibroblast monolayers: two-cell entities. Immunology 1982;45:371-80.
14. Levi-Schaffer F, Austen KF, Gravallese PH, Stevens RL. Coculture of IL-3 dependent mouse mast cells with fibroblasts results in a phenotypic change of mast cells. Proc Natl Acad Sci USA 1986;83:6485-91.
15. Czarnetzki BM, Sterry W, Bazin H, Kalveram KJ. Evidence that tissue mast cells derive from mononuclear phagocytes. Int Archs Allergy appl Immunol 1982;67:44-8.
16. Czarnetzki BM, Figdor CG, Kolde G, Vroom T, Aalberse R, de Vries JE. Development of human connective tissue mast cells from purified blood monocytes. Immunology 1984;51:549-54.
17. Welker P, Grabbe J, Hakimi J, Walls AF, Ostmeier H. Czarnetzki BM. Fibroblast-derived factors induce different mast cell characteristics in human myeloid cell lines and peripheral monocytes. Int Arch Allergy Immunol 1992;99:337-9.
18. Butterfield JH, Weiler D, Dewald G, Gleich GJ. Establishment of an immature mast cell line from a patient with mast cell leukemia. Leukemia Res 1988;12:435-55.
19. Furitsu T, Tsujujima T, Ikeda H et al. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product. J Clin Invest 1993;99:1736-44.
20. Kitayama H, Kanakura Y, Firutsu T et al. Constitutively activating mutations of c-kit receptor tyrosine kinase confer factor-independent growth and tumorigenicity of factor-dependent hematopoietic cell lines. Blood 1995;85:790-8.
21. Hashimoto K, Tsujimura T, Moriyama Y et al. Transforming and differentiation-inducing potential of constitutively activated c-kit mutant genes in the IC-2 murine interleukin 3-dependent mast cell line. J Pathol 1996;148:189-200.
22. Kishi K. A new leukemic cell line with Philadelphia chromosome characterized as basophil precursors. Leuk Res 1985;9:381-90.
23. Hamann K, Grabbe J, Welker P, Haas N, Algermissen B, Czarnetzki BM. Phenotypic evaluation of cultured human mast and basophilic cells and of normal human skin mast cells. Arch Dermatol Res 1994;286:380-5.
24. Blom T, Huang R, Aveskogh M, Nilsson K, Hellman L. Phenotypic characterization of KU812, a cell line identified as immature human basophilic leukocytes. Eur J Immunol 1992;22:2025-32.
25. Riske F, Hakimi M, Mallamaci M et al. High affinity human IgE receptor (FcεRI). Analysis of functional domains of the α-subunit with monoclonal antibodies. J Biol Chem 1991;266:11245-51.
26. Walls AF, Jones DB, Williams JH, Church MK, Holegate ST. Immunohistochemical identification of mast cells in formaldehyde-fixed tissue using monoclonal antibodies specific for tryptase. J Pathol 1990;162:119-26.
27. Lerner NB, Nocka KH, Cole SR et al. Monoclonal antibody YB5.B8 identifies the human c-kit protein product. Blood 1991;77:1876-83.
28. Weber S, Babina M, Krüger-Krasagakes S, Grützkau A, Henz BM. A subclone (5C6) of the human mast cell line HMC-1 represents a more differentiated phenotype than the original cell line. Arch Derm Res 1996;288:778-82.
29. Sambrock J, Fritsch EF, Maniatis T. Analysis of RNA. In: Ford N, Nolan C, Ferguson M. eds. Molecular Cloning, ed. 2. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989:7.1-7.87.
30. Wang B, Rieger A, Kilgus O et al. Epidermal Langerhans cells from normal human skin bind monomeric IgE via Fc epsilon RI. Exp Med 1992;172:1353-65.
31. Miller JS, Westin EH, Schwartz LB. Cloning and characterisation of complementary DNA for human tryptase. J Clin Invest 1989; 84:1188-95.
32. Ratajczak MZ, Luger SM, DeRiel J, Abraham J, Calabretta B, Gewirtz AM. Role of c-KIT protooncogen in normal and malignant human hematopoiesis. Proc Natl Acad Sci USA 1992;89:1710-4.
33. Togunaga K, Nakamura Y, Sakata K et al. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers. Cancer Res 1987;47:5616-9.
34. Sambrock J, Fritsch EF, Maniatis T. Analysis of genomic DNA. In: Ford N, Nolan C, Ferguson M, eds. Molecular Cloning, ed. 2. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 1989:9.31-9.57.
35. 4 release from human mast cells. Biochim Biophys Acta 1995; 1269:79-84.
36. Möller A, Lippert U, Lessmann D et al. Human mast cells produce IL-8. J Immunol 1993;151:3261-6.
37. Harvima IT, Schechter NM, Harvima RJ, Fraeke JE. Human skin tryptase: purification, partial characterization and comparison with human lung tryptase. Biochim Biophys Acta 1988;957:71-80.
38. Büttner C, Henz BM, Sepp N, Grabbe J. Identification of an activating c-kit mutation in adult-but not in childhood onset indolent mastocytosis: a possible explanation for divergent clinical behavior. J Invest Dermatol 1998; in press.
39. Nilsson G, Butterfield JH, Nilsson K, Siegbahn A. Stem cell factor is a chemotactic factor for human mast cells. J Immunol 1994; 153:3717-23.
40. Wu H, Klingmüller U, Besmer P, Lodish HF. Interaction of the erythropoietin and stem cell factor receptors. Nature 1995;377: 242-6.
41. Krüger-Krasagakes S, Möller AM, Kolde G, Lippert U, Weber S, Henz BM. Production of interleukin-6 by human mast cells and basophilic cells. J Invest Dermatol 1996;106:75-9.
42. Krüger-Krasagakes S, Grützkau A, Baghramian R, Czarnetzki BM. Interactions of immature human mast cells with extracellular matrix: expression of specific adhesion receptors and their role in cell binding to matrix proteins. J Invest Dermatol 1996;106:538-43.
43. Hartmann K, Henz BM, Krüger-Krasagakes S et al. C3a and C5a stimulate chemotaxis of human mast cells. Blood 1997;89:2863-70.
44. Babina M, Weber S, Henz BM. CD43 (leukosialin, sialophorin) expression is differentially regulated by retinoic acids. Eur J Immunol 1997;27:1147-51.
45. Weber S, Babina M, Feller G, Henz BM. Human leukemic (HMC-1) and normal skin mast cells express β2 integrins: characterization of β2 integrins and ICAM-1 on HMC-1 cells. Scand J Immunol 1997;45:471-81.
46. Welker P, Grabbe J, Czarnetzki BM. Human keratinocytes release mast cell differentiation factors other than SCF. Int Arch Allergy Appl Immunol 1995;107:139-41.
47. Welker P, Grabbe J, Grützkau A, Henz BM. Influence of the growth factors NGF and GM-CSF on the expression of mast cell characteristics. J Allergy Clin Immunol 1996;97:266.
48. Welker P, Grabbe J, Zuberbier T, Henz BM. GM-CSF down-regulates mast cell specific tryptase, FcεRI and histamine. Int Arch Allergy Appl Immunol 1997;113:284-6.
49. Matsuda H, Kannan Y, Ushio H et al. Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 1991;174:7-14.
50. Horigome K, Bullock ED, Johansson EM Jr. Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate early gene induction. J Biol Chem 1994;269:2695-702.
51. Li L, Macpherson JJ, Adelstein S et al. Conditioned medium from a cell strain derived from a patient with mastocytosis induces the development of mature human mast cells in vitro from normal human bone marrow. Int Arch Allergy Immunol 1995; 107:142-4.